Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA issues adulterated supplement warnings

This article was originally published in The Tan Sheet

Executive Summary

FDA warns consumers to stop taking Slim-30 Herb Supplement, a weight- loss supplement that contains undeclared sibutramine. Sibutramine is an FDA-approved product, but the agency has not approved Slim-30 Herb Supplements, so its safety in the product is unknown. Sibutramine may present a "significant risk" to patients with congestive heart failure, stroke or other cardiac conditions, FDA says. The agency also warns consumers not to take Joyful Slim Herb Supplement, marketed by J&H Besta Corp., because it contains undeclared desmethyl sibutramine. The company announced July 22 a recall of product lot 101408 including 30-count bottles with the UPC 897966002007. In addition, Good Health Inc. recalls Vialipro, a product marketed as a supplement for sexual enhancement. The firm said July 16 that FDA found sulfoaildenafil, an analogue of the pharmaceutical ingredient sildenafil, in certain batches. FDA previously warned of criminal charges for undeclared pharmaceuticals in OTC drugs, and has issued warnings leading to recalls of tainted supplements

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel